Here we aimed to dynamically track <i>KRAS</i> p. G12C genomic variations by integrating methylation profile in a longitudinal series of n = 91 liquid biopsy samples from n = 22 p. G12C positive NSCLC patients treated with sotorasib. This evidence concerns the gene KRAS and non-small cell lung carcinoma.